Brazilian guidelines for the diagnosis, treatment and prevention of rheumatic fever;Diretrizes Brasileiras para o diagnóstico, tratamento e prevenção da febre reumática

Arquivos Brasileiros de Cardiologia

Volumn 93, Issue 3 SUPPL. 4, 2009, Pages 1-18

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BRAZIL; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; RHEUMATIC FEVER; ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN;

BRAZIL; DIAGNOSIS, DIFFERENTIAL; HUMANS; RHEUMATIC FEVER;

EID: 79952197635     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009002100001     Document Type: Review

References (96)

1. American College of Cardiology Foundation, American Heart Association. Methodology Manual for ACCF/AHA Guideline Writing Committees: methodologies and policies from the ACCF/AHA task force on practice guidelines. 2009 Mar. Disponível em: www.americanheart.org/presenter. jhtml?identifier=3039683.
2. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation on rheumatic fever and rheumatic heart disease. World Health Organization. Geneva, 2001 Oct 29 - Nov 1. Geneva: WHO; 2004.
3. Kaplan EL. Recent epidemiology of group A streptococcal infections in North America and abroad: an overview. Pediatrics. 1996 Jun; 97 (6 Pt. 2): 945-8. (Pubitemid 26172646)
4. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation on rheumatic fever and rheumatic heart disease. World Health Organization. Geneva: 2001.
5. Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilario MO. Resource utilization and cost of rheumatic fever. J Rheumato. 2001 Jun; 28 (6): 1394-7. (Pubitemid 32510514)
6. Ministério da Saúde (BR) [Internet]. Sistema de Informações Hospitalares do SUS (SIH/SUS). Disponível em: http://w3.datasus.gov.br/datasus/datasus.php.
7. Xavier RMA, Nolasco M, Muller R, Santos M, Lima ABR, Lucas MJ, et al. PREFERE: da informação à prevenção. Editorial Laranjeiras. 2004; 1(4): 61-63.
8. Muller RE. Estudo longitudinal de pacientes portadores de cardiopatia reumática no Rio de Janeiro [Dissertação de Mestrado]. Rio de Janeiro: Ministério da Saúde/FIOCRUZ; 2008.
9. Meira ZMA, de Castilho SR, Barros MVL, Vitarelli AM, Capanema FD, Moreira NS, et al. Prevalence of rheumatic fever in children from a public high school in Belo Horizonte. Arq Bras Cardiol. 1995 Oct; 65 (4): 331-4.
10. Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002). Cardiovasc J Afr. 2008 May-Jun; 19 (3): 135-40.
11. Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr. 1992 Oct; 121 (4): 569-72.
12. Bach JF, Chalons S, Forier E, Elana G, Jouanelle J, Kayemba S, et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet. 1996 Mar 9; 347 (9002): 644-8. (Pubitemid 26076130)
13. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005 Nov; 5 (11): 685-94. (Pubitemid 41505357)
14. Saxena A, Kumar RK, Gera RP, Radhakrishnan S, Mishra S, Ahmed Z. Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease. Indian Pediatr. 2008 Jul; 45 (7): 565-73. (Pubitemid 351968799)
15. Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in brazilian children and adolescents. Heart. 2005 Aug; 91 (8): 1019-22. (Pubitemid 41060006)
16. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000 Jul; 13 (3): 470-511. (Pubitemid 30452618)
17. Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol. 2007 Aug-Sep; 66 (2-3): 199-207. (Pubitemid 47064375)
18. Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PM, Assis RV, et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation. 1995 Aug 1; 92 (3): 415-20.
19. Guilherme L, Cury P, Demarchi LM, Coelho V, Abel L, Lopez AP, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol. 2004 Nov; 165 (5): 1583-91. (Pubitemid 39435157)
20. Guilherme L, Oshiro SE, Fae KC, Cunha-Neto E, Renesto G, Goldberg AC, et al. T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun. 2001 Sep; 69 (9): 5345-51. (Pubitemid 32786466)
21. Jones TD. The diagnosis of rheumatic fever. JAMA. 1944; 126: 481-4.
22. Dajani AS. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, 1992 update. Special writing group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease on the Council of Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992; 268: 2069-73.
23. Dajani AS, Ayoub E, Bierman FZ. Guidelines for diagnosis of rheumatic fever: Jones Criteria, 1992 updated. Circulation. 1993; 87: 302-7.
24. Gray GC, Struewing JP, Hyams KC, Escamilla J, Tupponce AK, Kaplan EL. Interpreting a single antistreptolysin O test: a comparison of the "upper limit of normal" and likelihood ratio methods. J Clin Epidemiol. 1993 Oct; 46 (10): 1181-5. (Pubitemid 23302085)
25. Dajani AS. Current status of nonsuppurative complications of group A streptococci. Pediatr Infect Dis J. 1991; 10 (Suppl.): S25-S7.
26. Bisno AL, Gerber MA, Gwaltney Jr JM, Kaplan EL, Schwartz RH; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002; 35: 113-25.
27. American Academy of Pediatrics. Group A streptococcal infections. In: Pickering LK, editor. Red Book 2003: report of the Committeee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003. p. 573-84.
28. Machado CSM, Ortiz K, Martins ALB, Martins RS, Machado NC. Antistreptolysin O titer profile in acute rheumatic fever diagnosis. J Pediatr. (Rio J). 2001 Mar-Apr; 77 (2): 105-11.
29. Barash J, Mashiach E, Navon-Elkan P, et al. Differentiation of post-Streptococcal reactive arthritis from acute rheumatic fever. J Pediatr. 2008; 15 (3): 696-9.
30. Homer C, Shulman ST. Clinical aspects of acute rheumatic fever. J Rheumatol Suppl. 1991 Apr; 29: 2-13.
31. Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics. 2004 Mar; 113 (3 Pt. 1): e168-72.
32. Juneja R, Tandon R. Rheumatic carditis: a reappraisal. Indian Heart J. 2004 May-Jun; 56 (3): 252-5. (Pubitemid 39382066)
33. Lanna CC, Tonelli E, Barros MV, Goulart EM, Mota CC. Subclinical rheumatic valvitis: a long-term follow-up. Cardiol Young. 2003 Oct; 13 (5): 431-8. (Pubitemid 41630965)
34. Caldas AM, Terreri MT, Moises VA, Silva CM, Carvalho AC, Hilario MO. The case for utilizing more strict quantitative Doppler echocardiographic criterions for diagnosis of subclinical rheumatic carditis. Cardiol Young. 2007 Feb; 17 (1): 42-7. (Pubitemid 46322008)
35. Décourt LV. Doença reumática. São Paulo: Editora Savier; 1972.
36. Meira Z. Cardiopatia reumática crônica em crianças e adolescentes: aspectos clínicos e ecoDopplercardiográficos, evolução e prognóstico. Belo Horizonte: UFMG; 2000.
37. Mota CCC, Anderson RH, editors. Rheumatic fever. In: Anderson R.H, et al (Orgs.). Pediatric Cardology. Londres: Elsevier; 2008.
38. Carapetis JR, Brown A, Walsh W; National Heart Foundation of Australia (RF/RHD guideline development working group), Cardiac Society of Australia and New Zealand. Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia: an evidence-based review. Heart Foundation; 2006.
39. Saraiva LR, Santos CL, de Aguiar IR. The prolongation of the QT interval in the acute rheumatic carditis: an enigma. Arq Bras Cardiol. 2006 Dec; 87 (6): e254-6.
40. Polat TB, Yalcin Y, Akdeniz C, Zeybek C, Erdem A, Celebi A. QT dispersion in acute rheumatic fever. Cardiol Young. 2006 Apr; 16 (2): 141-6. (Pubitemid 44269394)
41. Carapetis JR, Brown A, Wilson NJ, Edwards KN; Rheumatic Fever Guidelines Writing Group. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust. 2007; 186: 581-6. (Pubitemid 46929640)
42. Tubridy-Clark M, Carapetis JR. Subclinical carditis in rheumatic fever: a systematic review. Int J Cardiol. 2007 Jun 25; 119 (1): 54-8. (Pubitemid 46824145)
43. Meira ZMA, Goulart EMA, Mota CCC. Comparative study of clinical and Doppler echocardiographic evaluations of the progression of valve diseases in children and adolescents with rheumatic fever. Arq Bras Cardiol. 2006 Jan; 86 (1): 32-8.
44. Veasy LG. Rheumatic fever: T. Duckett Jones and the rest of the story. Cardiol Young. 1995; 5: 293-301.
45. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007; 357 (5): 470-6. (Pubitemid 47204876)
46. Vasan R, Shrivastava S, Vijayakumar M, Narang R, Lister B, Narula J. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation. 1996; 94: 73-82. (Pubitemid 126426402)
47. Narula J, Malhotra A, Yasuda T, Talwar KK, Reddy KS, Chopra P, et al. Usefulness of antimyosin antibody imaging for the detection of active rheumatic myocarditis. Am J Cardiol. 1999 Oct 15; 84 (8): 946-50, A7.
48. Taran LM. The treatment of acute rheumatic fever and acute rheumatic heart disease. Am J Med. 1947; 2: 285-95.
49. Barlow JB, Marcus RH, Pocock WA, Barlow CW, Essop R, Sareli P. Mechanisms and management of heart failure in active rheumatic carditis. S Afr Med J. 1990 Aug 18; 78 (4): 181-6. (Pubitemid 20294304)
50. Da Silva NA, Pereira BA. Acute rheumatic fever. Still a challenge. Rheum Dis Clin North Am. 1997 Aug; 23 (3): 545-68.
51. Atatoa-Carr P, Lennon D, Wilson N. Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. N Z Med J. 2008 Apr 4; 121 (1271): 59-69. (Pubitemid 351818416)
52. Mortimer EA Jr., Vaisman S, Vignau A, Guasch J, Schuster A, Rakita L, et al. The effect of penicillin on acute rheumatic fever and valvular heart disease. N Engl J Med. 1959 Jan 15; 260 (3): 101-12.
53. Uziel Y, Hashkes PJ, Kassem E, Padeh S, Goldman R, Wolach B. The use of naproxen in the treatment of children with rheumatic fever. J Pediatr. 2000 Aug; 137 (2): 269-71. (Pubitemid 30659241)
54. Hashkes PJ, Tauber T, Somekh E, Brik R, Barash J, Mukamel M, et al. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial. J Pediatr. 2003 Sep; 143 (3): 399-401. (Pubitemid 37188328)
55. Aviles RJ, Ramakrishna G, Mohr DN, Michet CJ Jr. Poststreptococcal reactive arthritis in adults: a case series. Mayo Clin Proc. 2000 Feb; 75 (2): 144-7.
56. Dzhuzenova BS, Nasonova VA. The results of the indomethacin treatment of patients with acute rheumatic fever. Ter Arkh. 1991; 63 (12): 95-9.
57. Cilliers AM, Manyemba J, Saloojee H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev. 2003; (2): CD003176.
58. Illingworth RS, Lorber J, Holt KS, Rendle-Short J. Acute rheumatic fever in children: a comparison of six forms of treatment in 200 cases. Lancet. 1957 Oct 5; 273 (6997): 653-9.
59. Bywaters EG, Thomas GT. Bed rest, salicylates, and steroid in rheumatic fever. Br Med J. 1961 Jun 10; 1 (5240): 1628-34.
60. Pereira BAF; Associação Médica Brasileira, Conselho Federal de Medicina, Sociedade Brasileira de Pediatria. Projeto Diretrizes: febre reumática [Internet]. 2002. Disponível em: http://www.projetodiretrizes.org.br/projeto-diretrizes/051.pdf.
61. Alsaeid K, Majeed HA. Acute rheumatic fever: diagnosis and treatment. Pediatr Ann. 1998 May; 27 (5): 295-300.
62. Herdy GV, Pinto CA, Olivaes MC, Carvalho EA, Tchou H, Cosendey R, et al. Rheumatic carditis treated with high doses of pulsetherapy methylprednisolone. Results in 70 children over 12 years. Arq Bras Cardiol. 1999; 72 (5): 601-6.
63. Camara EJ, Braga JC, Alves-Silva LS, Camara GF, da Silva Lopes AA. Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: a randomized clinical trial. Cardiol Young. 2002 Mar; 12 (2): 119-24. (Pubitemid 41246638)
64. Herdy GV. Pulse therapy (high venous of venous methylprednisolone) in children with rheumatic carditis. Prospective study of 40 episodes. Arq Bras Cardiol. 1993; 60 (6): 377-81.
65. Al Kasab S, Al Fagih MR, Shahid M, Habbab M, Al Zaibag M. Valve surgery in acute rheumatic heart disease: one-to four-year follow-up. Chest. 1988 Oct; 94 (4): 830-3.
66. Pena J, Mora E, Cardozo J, Molina O, Montiel C. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients. Arq Neuropsiquiatr. 2002 Jun; 60 (2-B): 374-7. (Pubitemid 34728734)
67. Genel F, Arslanoglu S, Uran N, Saylan B. Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 2002 Mar; 24 (2): 73-6. (Pubitemid 34224906)
68. Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol. 2006 Apr; 34 (4): 264-9.
69. Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005 May; 20 (5): 424-9. (Pubitemid 40873048)
70. Stollerman GH, Rusoff JH, Hirschfield I. Prophylaxis against Group A streptococci in rheumatic fever. The use of single monthly injections of benzathine penicillin G. N Engl J Med. 1955; 252 (10): 787-92.
71. Bland EF, Jones TD. Rheumatic fever and rheumatic heart disease: a twenty year report on 1.000 patients followed since childhood. Circulation. 1951; 4: 836-43.
72. Bisno AL, Gerber MA, Gwaltney JM Jr., Kaplan EL, Schwartz RH; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002 Jul 15; 35 (2): 113-25.
73. Martin JM, Green M. Group A streptococcus. Semin Pediatr Infect Dis. 2006 Jul; 17 (3): 140-8. (Pubitemid 44278621)
74. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovascular Disorders. 2005; 5: 11.
75. Beggs S, Peterson G, Tompson A. Antibiotic use for the prevention and treatment of rheumatic fever and rheumatic heart disease in children. Report for the 2nd Meeting of World Health Organization's subcommittee of the Expert Committee of the Selection and Use of Essential Medicines; 2008 Oct 29-Sept 3; Geneva: WHO; 2008.
76. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al; American Academy of Pediatrics. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2009; 119: 1541-51.
77. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005 Apr; 115 (4): 1048-57.
78. Gerber MA. Antibiotic resistance in group A streptococci. Pediatr Clin North Am. 1995; 42: 539-51.
79. Stollerman GH. Treatment and management in rheumatic fever and streptococcal infection. New York Grune & Stratton, Inc; 1975. p. 227-76.
80. Cohen R, Reinert P, De La Rocque F, Levy C, Boucherat M, Robert M, et al. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2002 Apr; 21 (4): 297-303. (Pubitemid 34326867)
81. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005; 366: 155-68. (Pubitemid 40991218)
82. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics. 1995 Oct; 96 (4 Pt. 1): 758-64.
83. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002; (3): CD002227.
84. Meira ZMA, Mota CCC, Tonelli E. Evaluation of secundary prophylatics schemes based on benzatine penicillin G for rheumatic fever in children. J Pediatr. 1993; 123: 156-7.
85. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN. Long-term outcome of patients with rheumatic fever receiving benzatine penicillin G prophylaxis every three weeks versus four weeks. J Pediatr. 1994; 125 (5 Pt. 1): 812-6.
86. Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J. 1998 Oct; 17 (10): 890-3. (Pubitemid 28506410)
87. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991;337: 1308-10.
88. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998 Jan; 101 (1 Pt. 1): 33-7. (Pubitemid 28112878)
89. Ministério da Saúde. Portaria no. 156 de 20 de janeiro de 2006. Dispõe sobre o uso da penicilina na atenção básica à saúde e nas demais unidades do Sistema Único de Saúde (SUS). Diário Oficial da União. 2006; 15 (1): 54.
90. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases (USA) [Internet]. Jordan Reporter 2007: accelerated development of vaccines. Disponível em: http://www3.niaid.nih.gov/about/organization/dmid/PDF/Jordan2007.pdf.
91. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005 Oct 15; 41 (8): 1114-22. (Pubitemid 41429473)
92. Medaglini D, Pozzi G, King TP, Fischetti VA. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A. 1995 Jul 18; 92 (15): 6868-72.
93. Kotloff KL, Wasserman SS, Jones KF, Livio S, Hruby DE, Franke CA, et al. Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine. Infect Immun. 2005 Apr; 73 (4): 2360-6. (Pubitemid 40470839)
94. Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet. 1994 Sep 3; 344 (8923): 639-42. (Pubitemid 24274307)
95. Olive C, Hsien K, Horvath A, Clair T, Yarwood P, Toth I, et al. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Vaccine. 2005 Mar 18; 23 (17-18): 2298-303. (Pubitemid 40341471)
96. Guilherme L, Fae KC, Higa F, Chaves L, Oshiro SE, Freschi de Barros S, et al. Towards a vaccine against rheumatic fever. Clin Dev Immunol. 2006 Jun-Dec; 13 (2-4): 125-32. (Pubitemid 44950031)